A F M Motiur Rahman | Bio-chemicals | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr A F M Motiur Rahman | liquidos ionicos | Best Researcher Award

Associate Professor at Pharmaceutical Chemistry, Saudi Arabia

A dedicated pharmaceutical scientist, Assoc. Prof. Dr A F M Motiur Rahman holds a Ph.D. from Yeungnam University, South Korea, with a strong foundation in medicinal chemistry, particularly in synthetic molecule design and drug metabolism. Serving as an Associate Professor at King Saud University, Saudi Arabia, he leads research in synthetic molecule development for anticancer applications, mentoring students across various academic levels. His work encompasses innovative synthesis and bio-conjugate chemistry, advancing cancer drug discovery through ongoing projects and published articles.

Publication Profile

scopus

orcid

Education šŸ…

Ph.D. in Pharmaceutical Science, Yeungnam University, South Korea, 2007M.Sc. in Organic Chemistry, University of Rajshahi, Bangladesh, 2002B.Sc. in Chemistry (Honors), University of Rajshahi, Bangladesh, 2000H.S.C. in Science, Rajshahi Education Board, Bangladesh, 1995S.S.C. in Science, Rajshahi Education Board, Bangladesh, 1993

Experience šŸ‘©ā€šŸ«

Currently an Associate Professor at King Saud University,Assoc. Prof. Dr A F M Motiur Rahman has also served as Assistant Professor, Postdoctoral Research Associate at Kyungpook National University, and Research Professor at Yeungnam University. Heā€™s contributed to Frontiers in Chemistry and the Malaysian Journal of Medical and Biological Research, specializing in heterocyclic chemistry, chromatographic analysis, and organic molecule synthesis.

Awards and Honors šŸ†

Recipient of esteemed scholarships including NEDO Fellowship (Japan), BK21 Scholarship (South Korea), and multiple Korea Research Foundation Fellowships, Assoc. Prof. Dr A F M Motiur RahmanĀ  has received numerous recognitions, such as the Yeungnam University Ph.D. Scholarship, reflecting his impactful contributions to pharmaceutical chemistry and organic molecule synthesis.

Research Focus šŸ”¬

Specializing in anticancer agents, Assoc. Prof. Dr A F M Motiur RahmanĀ  leads research in synthesizing bioactive molecules, focusing on enzyme inhibitory activities, topoisomerase inhibition, and bio-conjugate chemistry. His projects emphasize metabolic profiling of synthesized molecules, advancing anticancer drug discovery through the design of synthetic and natural compounds for targeted therapies.

PublicationĀ  Top Notes

DNA-binding and Anticancer Research

Title: Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes

Journal: Journal of Molecular Structure, 2025, 1321, Article 140044

Authors: Zhang, D., Li, M., Rahman, A.F.M.M., Liu, Z., Lu, Y.

Citations: 0

Multitarget Anticancer Agents

Title: Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents

Journal: ACS Omega, 2024, 9(40), Pages 41944ā€“41967

Authors: Saadan, N.M., Ahmed, W.U., Kadi, A.A., Al-Wabli, R.I., Rahman, A.F.M.M.

Citations: 0

Dual Inhibition in Cancer Therapy

Title: Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2

Journal: Journal of Molecular Structure, 2024, 1309, Article 138177

Authors: Mirgany, T.O., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 1

Antibacterial Compound Discovery

Title: New antibacterial penicimenolide G with unusual 12-membered resorcylic acid lactone ring isolated from Aspergillus giganteus

Journal: Phytochemistry Letters, 2024, 62, Pages 18ā€“23

Authors: Shamim, A.H.M., Mondol, M.A.M., Hossain, M., Alharbi, H.A., Rahman, A.F.M.M.

Citations: 0

Multi-Kinase Inhibitors Development

Title: Discovery of 1H-benzo[d]imidazole-(halogenated)benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors

Journal: Pharmaceuticals, 2024, 17(7), Article 839

Authors: Mirgany, T.O., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 0

Anticancer Photophysical Studies

Title: Synthesis, Cytotoxicity, and Photophysical Investigations of 2-Amino-4,6-diphenylnicotinonitriles

Journal: Molecules, 2024, 29(8), Article 1808

Authors: Al-Ghamdi, A.R., Rahman, S., Al-Wabli, R.I., Al-Mutairi, M.S., Rahman, A.F.M.M.

Citations: 0

Solar Cell Efficiency

Title: The photon-electrical conversion efficiency of dye-sensitive solar cells fabricated using silver-nanoparticle/titania photocathode

Journal: Applied Research, 2024, 3(1), Article e202300044

Authors: Daniel, L.S., Kaffer, R.T., Kalipi, L.M., Kalengay, M., Uahengo, V.

Citations: 0

Nano Drug Delivery System for Brain

Title: Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407

Journal: Journal of Nanoparticle Research, 2024, 26(1), Article 12

Authors: Shariare, M.H., Mannan, M., Khan, F., Uddin, M.N., Kazi, M.

Citations: 2

Pyrrolo[2,3-d]pyrimidine Kinase Inhibitors

Title: Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers

Journal: Pharmaceuticals, 2023, 16(9), Article 1324

Authors: Alotaibi, A.A., Alanazi, M.M., Rahman, A.F.M.M.

Citations: 4

Selective Kinase Inhibition

Title: Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity

Journal: Journal of Saudi Chemical Society, 2023, 27(5), Article 101712

Authors: Alotaibi, A.A., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 10

Conclusion

Given the candidateā€™s robust academic qualifications, international research experience, successful mentorship, and strong track record in pharmaceutical and organic chemistry research, they are exceptionally suited for the Best Researcher Award. Their commitment to teaching, funding acquisition, and contributions to therapeutic compound development mark them as a distinguished researcher who has made impactful contributions to the field. Further engagement in publishing and interdisciplinary initiatives could enhance their already strong candidacy, positioning them as a future leader in pharmaceutical chemistry and organic synthesis.